हिंदी में पढ़ें
Banking & Financial Services
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
MF Returns Calculator
Aurobindo Pharma News
Stock Market Today: Sensex, Nifty dip after range-bound intraday trade; Bharti Airtel, Aurobindo Pharma shares bleed
Thu, Aug 13, 2020
Stock Market Today: The BSE Sensex lost 59 points and closed at 38,310 mark while the NSE Nifty went down 7 points and closed at 11,300 levels. Bank Nifty index went down 67 points and closed at 22,196 mark.
Aurobindo Pharma share price: Most early gains given up, but still closes over 1 pct higher
Fri, Jun 05, 2020
Aurobindo Pharma share price: Shares of Aurobindo Pharma on Thursday gave up most of their early gains on profit-booking and closed over 1 per cent higher.
Stocks in Focus on June 4: BPCL, HDFC Life to Pharma Companies; here are expected newsmakers of the day
Thu, Jun 04, 2020
Stocks in Focus on June 4: BPCL, HDFC Life, Aurobindo Pharma, Sun Pharma, etc. are expected to remain newsmakers throughout the intraday trade session.
Why Aurobindo Pharma-Sandoz deal fell apart? Check brokers' reactions
Fri, Apr 03, 2020
Hyderabad-based Aurobindo Pharma's decision to break its deal with Sandoz will likely impact the company and its stocks according to analysts who track the sector. The biggest reason why this decision has been taken is due to the company not getting approval from US Federal Trade Commission (FTC)
Cipla share price plunges nearly 6 pct after USFDA issues warning letter for Goa facility
Wed, Feb 26, 2020
Cipla tumbled nearly 6 per cent after the US health regulator issued a warning letter for its Goa manufacturing facility.
Sensex, Nifty rise ahead of US-China trade deal; NALCO, Hero MotoCorp, Aurobindo Pharma stocks gain
Tue, Jan 14, 2020
The stock market of Indian trade range-bound ahead of the much-awaited US-China trade deal scheduled on 15th January 2020. The BSE Sensex rose 92 points and closed at 41,952 levels while the 50-stocks Nifty went up 32 points and closed at 12,362 levels.
Sensex, Nifty slip on sixth straight trade session; Aurobindo Pharma, DHFL, Ashok Leyland stocks bleed
Mon, Oct 07, 2019
The stock market of India sinks on sixth straight trade session. The BSE Sensex lost 141 points and closed at 37,531 levels while the 50-stock Nifty went down 48 points and closed at 11,126 level after the closing bell trade session.
Sensex soars over 600 points, Nifty climbs 11K, Bank Nifty scales 28K; Aurobindo Pharma, Vodafone Idea stocks gain
Thu, Aug 08, 2019
The BSE Sensex shot up 636 points and closed at 37,327 levels while the Nifty-50 index scaled 11,000 levels after gaining 176 points today. The Bank Nifty index shot up 408 points and closed above 28,00 levels at 28,110 levels.
Sensex, Nifty find comfort in Chinese trade data, yuan fix; Aurobindo Pharma, Yes Bank stocks gain
Thu, Aug 08, 2019
The BSE Sensex opened 175 point sup at 36,866 levels while the 50-stock Nifty opened 58 points higher at 10,913 levels. the Bank Nifty index was 117 points up at 27,819 levels.
Stocks in Focus on July 11: Infra stocks, DHFL to Ajmera Realty; here are the 5 Newsmakers of the Day
Thu, Jul 11, 2019
There are certain stocks that came in news after the market was closed on Wednesday and can play a pivotal role on Thursday intraday trade.
Aurobindo Pharma completes $300 mn deal to acquire 7 oncology products from US-based firm.
Sat, Mar 02, 2019
According to the definitive agreements inked between the two companies, Acrotech Biopharma LLC, a subsidiary of Aurobindo, will pay an upfront purchase price of USD 160 million in cash plus up to USD 140 million on achieving regulatory and sales-based milestones for the seven products.
Pharma sector outlook 2019 in India: Expect big recovery in New Year; IPCA, Divis Lab champions of 2018
Mon, Dec 31, 2018
The sector has been volatile throughout the year due to constant news flow in the markets. Some giants of the sector witnessed objections over their manufacturing plants and medicine pricing in the U.S. markets.
Aurobindo Pharma touches all-time high, soars by 9% on Sandoz deal
Fri, Sep 07, 2018
With the blockbaster performance of today Aurobindo Pharma has now given a performance of 56.78% in a year.
Aurobindo Pharma acquires Apotex Inc for 74 mn euros
Sun, Jul 15, 2018
Transaction will be made wholly in cash, for which Aurobindo will pay about 74 million euros (which is approx Rs 5 billion). The company will not assume any debt as part of this transaction.
Aurobindo Pharma plant inspection: FDA team finds 'female mosquito' in its facility
Sun, Mar 11, 2018
Aurobindo Pharma facility inspection: The US FDA had issued nine observations after inspection of the drug maker's Unit 4 formulation facility near Hyderabad last month
FAST MONEY: Saksoft, Aurobindo Pharma among 10 buy and sell calls for today's trade
Thu, Feb 22, 2018
The domestic market is expected to open lower, tracking Asian markets, which slipped on Thursday as the risk of faster hikes in US interest rates lifted short-term Treasury yields to the highest in almost a decade and boosted the dollar.
Goldman Sachs picks four Indian companies for its Asia Stock Collection; look how they performed in one year
Wed, Jun 21, 2017
"Asia is the home of Active. From Alibaba to Yili, Alps to Maruti, we go back to first principles on our differentiated, liquid and idiosyncratic stock ideas in Asia", Goldman Sachs said in Asia Stock Collection report.
Aurobindo Pharma eyes US plant amid Trump push on jobs
Fri, Feb 10, 2017
India`s drug industry is worth about $15 billion and supplies roughly 30 percent of the medicines sold in the United States.
BSE, telecom shares open flat; Aurobindo Pharma drops
Fri, Oct 07, 2016
Shares of telecom companies like Bharti Airtel, Reliance Communications, Idea Cellular remained unresponsive after spectrum auction ended on Thursday.
Pharma likely to see double-digit revenue growth in first quarter
Tue, Jul 12, 2016
Surya Patra and Mehul Sheth of Phillip Capital said, in Q1FY17, pharma industry to see top-line and bottom-line growth by 16% and 24% respectively, primarily due to robust performance from Sun Pharma, led by its product gGleevec.